A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01)

  • Lau, David (Primary Chief Investigator (PCI))
  • Strickland, Andrew (Primary Chief Investigator (PCI))
  • Strickland, Andrew (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date30/01/24 → 29/01/29